Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
Abstract Background Alpha-fetoprotein (AFP) is produced by some tumors, such as hepatocellular carcinoma and yolk sac tumors, leading to an increase in serum AFP level. However, AFP in colorectal cancer is extremely rare. Treatment for AFP-producing cancer is often performed according to conventiona...
Main Authors: | Yuki Nakamura, Kenji Matsuda, Shozo Yokoyama, Koichi Tamura, Yasuyuki Mitani, Hiromitsu Iwamoto, Yuki Mizumoto, Daisuke Murakami, Masakazu Fujimoto, Hiroki Yamaue |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-09-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40792-018-0520-6 |
Similar Items
-
2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01) -
ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
The Role of Alpha-Fetoprotein (AFP) in Contemporary Oncology: The Path from a Diagnostic Biomarker to an Anticancer Drug
by: Joanna Głowska-Ciemny, et al.
Published: (2023-01-01) -
Elevated Second Trimester Alpha-Fetoprotein Increases the Risk of Placenta Accreta
by: Fengge Wang, et al.
Published: (2023-11-01) -
High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model
by: Patricia Griffin, et al.
Published: (2023-04-01)